SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-23-001806
Filing Date
2023-02-14
Accepted
2023-02-14 16:08:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 KINIKSA PHARMACEUTICALS, LTD. p23-0179sc13ga.htm SC 13G/A 41832
  Complete submission text file 0000902664-23-001806.txt   43662
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Subject) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90491 | Film No.: 23629128
SIC: 2834 Pharmaceutical Preparations

Mailing Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006
Business Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006 (345) 749-8643
HHLR ADVISORS, LTD. (Filed by) CIK: 0001762304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A